Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jinfeng Liu
Institutions:
Nanjing University of Chinese Medicine,
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
Observed institutions:
Nanjing University of Chinese Medicine,
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
ORCID:
0009-0009-6719-3461
Observed ORCID:
0009-0009-6719-3461
OpenAlex ID:
A5133860117
Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
2026
·
Na Li
, Shurong Li
, et al.
·
Cancer Gene Therapy
·
2
Drug-induced neutropenia: A comprehensive pharmacovigilance study of the FAERS database
2026
·
Jie Li
, Yilei Wang
, et al.
·
Medicine
·
1
Mechanisms of PARP Inhibitor Resistance and Potential Therapeutic Strategies in Breast Cancer
2026
·
Chengqian Zhou
, Xiaotao Qian
, et al.
·
International Journal of Molecular Sciences
Genome-wide CRISPR screen identifies ATAD3A promotes acetaminophen-induced liver injury by driving ferroptosis
2026
·
Jinfeng Liu
, Zihan Gao
, et al.
·
Cell Death and Disease
PDF
ESCO2 Interacts with TRF1/2 and Facilitates Telomere Maintenance
2026
·
Jiahui Guo
, Jingjing Ji
, et al.
·
International Journal of Molecular Sciences
PDF
Show more works
View as search
Works count:
5
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type